광고닫기

BIOFT Earns T4 Technology Rating from Korea Technology Credit Rating

디지털 중앙

2026.09.30 23:46

  • 글자크기
  • 인쇄
  • 공유
글자 크기 조절
기사 공유
BIOFT Co., Ltd. (CEO Dae-hyun Kwon), a company specializing in biomaterial ingredient research and development and cosmetics ODM, has earned a T4 technology rating through the Technology Credit Bureau (TCB) assessment conducted by Korea Technology Credit Rating Co., Ltd.
 
[Image by BIOFT]

[Image by BIOFT]

Korea Technology Credit Rating evaluates companies’ technological capabilities, market potential, and business viability, assigning technology ratings from T1 to T10. The T4 rating awarded to BIOFT indicates sound competitiveness in technology and ideas, solid technology commercialization capabilities, and moderately high potential for future revenue generation.
 
Through its own research center, BIOFT directly researches, develops, and manufactures a wide range of biomaterial ingredients, including LNPs, liposomes, vegan PDRN, and recombinant PDRN. The company provides one-stop services encompassing customized ingredient development, formulation consulting, and finished cosmetics ODM, offering integrated support from ingredient development to product commercialization.
 
Building on its proprietary platform technologies, BIOFT continues to conduct research aimed at improving the stability and delivery efficiency of active ingredients while providing solutions tailored to customers’ product concepts and development objectives. These technological capabilities and customized development services have attracted interest from global buyers, helping the company expand overseas business opportunities through differentiated biomaterials and cosmetics ODM services.
 
Recently, BIOFT secured patent registration for LiCellsome, its next-generation dual-layer liposome technology combining liposome and LNP technologies. This achievement strengthens the technological foundation of its proprietary delivery platforms and enhances its competitiveness in developing differentiated active ingredients and formulations.
 
BIOFT also received the 2026 Korea Customer Satisfaction and Trust Award in the Bio-Cosmetics Research and Development category. The award recognizes the company’s efforts to provide customized ingredient and formulation solutions based on its biomaterial R&D capabilities. It also reflects BIOFT’s achievements in building customer satisfaction and trust through integrated services that address customer needs from ingredient development to finished product manufacturing.
 
Following its T4 rating, BIOFT plans to continue advancing biomaterial R&D and delivery technologies, strengthen its ODM capabilities by connecting ingredient development with finished product development, and expand collaboration with customers in Korea and overseas.
  

정현식 기자

많이 본 뉴스

      실시간 뉴스